Capivasertib treatment associated with hypermetabolism of the spleen
Abstract Capivasertib has emerged as a promising treatment for advanced breast and prostate cancer. Here, we report two cases of metastatic breast cancer patients who developed splenic hypermetabolism on [18 F]-FDG PET/CT following treatment with capivasertib. To our knowledge, these are the first d...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer
2025-03-01
|
| Reeks: | EJNMMI Reports |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s41824-024-00231-7 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|